UL

Usha Laxmi

Active Director Director DIN 10846921
DIN 10846921 First appointment Nov 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Usha Laxmi

Data last updated:

Usha Laxmi is a Director at Veproxy Pharma India Private Limited (since 2024). The company operates in Paper.

DIN 10846921
Primary Designation Director
Industry Paper
First Appointment 22 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Veproxy Pharma India Private Limited U21009UP2024PTC212269
Director22 Nov 20242024Active

Board colleagues of Usha Laxmi

NameDINCompanyDesignation
Pranay Kumar Singh10846920Veproxy Pharma India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Veproxy Pharma India Private Limited
Premium access

Shareholding and investment profile for Usha Laxmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Laxmi

Usha Laxmi currently holds 1 directorship: Veproxy Pharma India Private Limited (Director, since 22 Nov 2024).

Usha Laxmi was first appointed on 22 Nov 2024 as Director at Veproxy Pharma India Private Limited.

The current boards of Usha Laxmi's companies include Pranay Kumar Singh (Veproxy Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available